- Home
- SDRL vs TVTX Comparison
SDRL vs TVTX Comparison
Compare SDRL & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDRL
- TVTX
- Stock Information
- Founded
- SDRL 2005
- TVTX 2008
- Country
- SDRL Bermuda
- TVTX United States
- Employees
- SDRL N/A
- TVTX N/A
- Industry
- SDRL Oil & Gas Production
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- SDRL Energy
- TVTX Health Care
- Exchange
- SDRL Nasdaq
- TVTX Nasdaq
- Market Cap
- SDRL 1.5B
- TVTX 1.4B
- IPO Year
- SDRL N/A
- TVTX N/A
- Fundamental
- Price
- SDRL $26.32
- TVTX $15.12
- Analyst Decision
- SDRL Strong Buy
- TVTX Strong Buy
- Analyst Count
- SDRL 5
- TVTX 15
- Target Price
- SDRL $56.50
- TVTX $33.57
- AVG Volume (30 Days)
- SDRL 1.4M
- TVTX 1.5M
- Earning Date
- SDRL 08-04-2025
- TVTX 07-31-2025
- Dividend Yield
- SDRL N/A
- TVTX N/A
- EPS Growth
- SDRL 37.29
- TVTX N/A
- EPS
- SDRL 5.56
- TVTX N/A
- Revenue
- SDRL $1,288,000,000.00
- TVTX $273,533,000.00
- Revenue This Year
- SDRL $3.80
- TVTX $73.84
- Revenue Next Year
- SDRL $5.71
- TVTX $46.72
- P/E Ratio
- SDRL $4.69
- TVTX N/A
- Revenue Growth
- SDRL N/A
- TVTX 75.65
- 52 Week Low
- SDRL $17.74
- TVTX $7.72
- 52 Week High
- SDRL $56.46
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- SDRL 48.40
- TVTX 44.23
- Support Level
- SDRL $25.57
- TVTX $13.97
- Resistance Level
- SDRL $29.41
- TVTX $15.30
- Average True Range (ATR)
- SDRL 1.18
- TVTX 0.71
- MACD
- SDRL -0.32
- TVTX 0.16
- Stochastic Oscillator
- SDRL 16.63
- TVTX 60.12
About SDRL Seadrill Limited
Seadrill Ltd is an offshore drilling contractor company. The company is engaged in providing offshore drilling services to the oil and gas industry. The primary business of the company is the ownership and operation of drillships, semi-submersible rigs, and jack-up rigs for operations in shallow to ultra-deepwater areas in both benign and harsh environments. The geographical segments of the company are the United States, Brazil, Angola, Norway, Canada and others. The company derives maximum revenue from the United States.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.